Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Report 2026

Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Overview

• Artificial Intelligence Clinical Trial Protocol Feasibility Tool market size has reached to $0.83 billion in 2025 • Expected to grow to $2.76 billion in 2030 at a compound annual growth rate (CAGR) of 27% • Growth Driver: Rising Emphasis On Precision Medicine Fueling The Growth Of The Market Due To Advancements In Genomic Sequencing And Targeted Therapies • Market Trend: Predictive Analytics-Based Trial Planning Enhances Protocol Accuracy And Reduces Delays • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market?

An artificial intelligence clinical trial protocol feasibility tool is a software solution that uses AI algorithms to analyze historical clinical data, patient populations, and trial design parameters to assess the feasibility of a proposed clinical trial. Its primary purpose is to predict patient recruitment potential, identify protocol risks, and optimize trial design, thereby reducing delays and improving trial success rates. The main components of the artificial intelligence clinical trial protocol feasibility tool are software and services. Software is a digital platform that uses AI to evaluate clinical trial protocols, predict patient recruitment, identify risks, and optimize trial design for faster and more efficient studies. It is deployed through cloud-based and on-premises modes. The tool serves multiple applications, including protocol design, site selection, patient recruitment, risk assessment, and other applications, catering to various end users such as pharmaceutical and biotechnology companies, contract research organizations, academic and research institutes, and other end users.

What Is The Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Growth Forecast?

The artificial intelligence clinical trial protocol feasibility tool market size is expected to see exponential growth in the next few years. It will grow to $2.76 billion in 2030 at a compound annual growth rate (CAGR) of 27.0%. The growth in the forecast period can be attributed to increasing demand for faster trial approvals, rising adoption of decentralized trial designs, expansion of ai-enabled protocol optimization platforms, growing focus on trial cost reduction, increasing emphasis on predictive feasibility modeling. Major trends in the forecast period include increasing use of ai for protocol risk assessment, rising adoption of predictive recruitment modeling, growing integration of historical trial data, expansion of cloud-based feasibility tools, enhanced focus on trial design optimization.

Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Segmentation

1) By Component: Software, Services 2) By Deployment Mode: Cloud-Based, On-Premises 3) By Application: Protocol Design, Site Selection, Patient Recruitment, Risk Assessment, Other Applications 4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users Subsegments: 1) By Software: Predictive Analytics, Machine Learning, Natural Language Processing, Data Integration 2) By Services: Consulting, Implementation, Training And Support, Managed Services

What Is The Driver Of The Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market?

The rising emphasis on precision medicine is expected to propel the growth of the artificial intelligence clinical trial protocol feasibility tool market going forward. Precision medicine refers to a tailored healthcare approach that uses a patient’s genetics, environment, and lifestyle to provide more accurate and effective treatments. The increasing focus on precision medicine is due to advances in genomic sequencing and biomarker identification, as they enable precise detection and targeted therapies. Artificial intelligence clinical trial protocol feasibility tools enhance precision medicine by enabling data-driven trial design, making them ideal for tailoring treatments to individual patient populations. They reduce trial inefficiencies by predicting patient recruitment, timelines, and risks, improving clinical research accuracy and outcomes. For instance, in March 2024, Novotech, an Australia-based biotechnology company, in 2023, 43% of the 217 FDA-approved oncology therapies were precision oncology treatments, with 78 incorporating DNA or NGS-detectable biomarkers. Therefore, the rising emphasis on precision medicine is driving the growth of the artificial intelligence clinical trial protocol feasibility tool industry.

Key Players In The Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market

Major companies operating in the artificial intelligence clinical trial protocol feasibility tool market are IQVIA Holdings Inc., SAS Institute Inc., Veeva Systems Inc., Tempus AI Inc., Cytel Inc., ArisGlobal LLC., Saama Technologies Inc., Norstella, ConcertAI, Komodo Health Inc., H1 Inc., TriNetX Inc., ObjectiveHealth LLC, Lokavant Inc., Inato Inc., Clinerion Ltd., Faro Health Inc., Lantern Pharma Inc., Ryght AI, BEKHealth Corporation

Global Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Trends and Insights

Major companies operating in the artificial intelligence clinical trial protocol feasibility tool market are focusing on developing innovative solutions, such as predictive analytics-based trial planning software, to enhance protocol design accuracy and reduce trial delays. Predictive analytics-based trial planning software is a solution that uses historical and real-time clinical trial data to forecast timelines, identify potential risks, and optimize study design for more efficient and cost-effective trials. For instance, in June 2024, Lokavant Inc., a US-based clinical intelligence company, launched Spectrum, the first artificial intelligence clinical trial feasibility solution aimed at optimizing trials from strategic planning through mid-study re-forecasting. The platform features predictive analytics-based trial planning software that enables continuous, real-time feasibility analysis, timeline and cost prediction, and financial forecasting without manual intervention. Spectrum delivers dynamic, real-time (re)forecasting by integrating live trial data, allowing study teams to monitor progress, explore alternative scenarios, and optimize enrollment outcomes. This solution also provides highly accurate predictions for timelines, costs, and operational risks, supporting faster, data-driven decision-making throughout the clinical trial lifecycle.

What Are Latest Mergers And Acquisitions In The Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market?

In March 2025, Tempus AI Inc., a US-based health technology company, acquired Deep 6 AI for an undisclosed amount. With this acquisition, Tempus AI Inc. aims to accelerate patient recruitment, expand real-world data access, and advance precision medicine through enhanced AI-driven clinical trial matching. Deep 6 AI Inc. is a US-based company that offers advanced artificial intelligence clinical trial protocol feasibility tools.

Regional Outlook

North America was the largest region in the artificial intelligence clinical trial protocol feasibility tool market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market?

The artificial intelligence clinical trial protocol feasibility tool market includes revenues earned by entities through patient recruitment analysis, site selection optimization, protocol design feasibility, risk assessment and mitigation, and data integration and analytics services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Artificial Intelligence Clinical Trial Protocol Feasibility Tool Market Report 2026?

The artificial intelligence clinical trial protocol feasibility tool market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence clinical trial protocol feasibility tool industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.